Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
ID: 350823Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350823

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-039.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering an Exploratory Grant Award (R21) aimed at promoting workforce diversity in basic cancer research. This funding opportunity seeks to support New Investigators and Early Stage Investigators from underrepresented backgrounds in developing innovative cancer research studies, particularly those addressing health disparities among racial and ethnic minorities. The program is part of NIH's ongoing efforts to diversify the biomedical research workforce and enhance research capabilities, with a total award budget not exceeding $275,000 for a maximum period of two years. Interested applicants can find more information and application guidelines at the NIH website, with the application deadline set for November 17, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-039-Full-Announcement.html
    PAR-24-039.html
    The National Institutes of Health (NIH) announces an Exploratory Grant Award (R21) aimed at promoting workforce diversity in basic cancer research. This funding opportunity seeks to support New Investigators and Early Stage Investigators from underrepresented backgrounds in developing innovative cancer research studies. The initiative is a reissue of a previous program, continuing the NIH's effort to diversify biomedical research and enhance the research capabilities available to address health disparities. Applications are open for new, renewal, or resubmission proposals, with a total award budget not exceeding $275,000 for a maximum period of two years. The focus is on basic cancer biology research, particularly that which addresses cancer health disparities among racial and ethnic minorities. All applicants must comply with specific guidelines and submissions are reviewed based on scientific merit and innovation. The NIH underscores the importance of a diverse research workforce and expects this program to uplift talented researchers, ultimately advancing knowledge in cancer research and benefiting all segments of society. The application process is detailed, emphasizing the necessity of following NIH's application instructions strictly. Consequently, the program aims to foster a scientific community that contains varied perspectives and experiences, which is essential for tackling complex scientific questions effectively.
    Similar Opportunities
    Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Small Grants for New Investigators to Promote Diversity in Health-Related Research" (R21 Clinical Trial Optional) to support new investigators from diverse backgrounds in conducting small research projects. This funding opportunity aims to facilitate the transition to independent research careers for individuals who have not previously secured over $125,000 in direct costs of research funding, specifically targeting those from historically underrepresented groups in biomedical research. The grants, which can last up to three years with a maximum direct cost of $125,000 annually, are intended to foster innovation and address health disparities in underserved populations. Interested applicants must submit their proposals by January 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Basic Research in Cancer Health Disparities" under the R21 Exploratory/Developmental Research Grant mechanism. This initiative aims to support innovative research investigating the biological and genetic factors contributing to cancer health disparities among various racial and ethnic populations, with a focus on mechanistic studies and the development of new methodologies. The program is designed to foster collaboration among scientists and build a nationwide cohort dedicated to advancing the understanding of cancer disparities, ultimately leading to future R01 projects. Applications can be submitted starting September 16, 2024, with a budget cap of $275,000 over two years, and the closing date for submissions is November 16, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01), a federal grant aimed at enhancing diversity within the cancer research workforce. This funding opportunity supports individuals from underrepresented backgrounds in biomedical and clinical sciences by providing salary and research support for a period of 3 to 5 years under the mentorship of experienced researchers, specifically for projects that do not involve leading independent clinical trials. The initiative is crucial for addressing disparities in cancer incidence and mortality rates among underserved populations, fostering a diverse pool of research talent, and promoting innovative solutions to complex health challenges. Interested applicants must submit their proposals by November 12, 2024, and can find additional information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required), aimed at enhancing diversity within the cancer research workforce. This grant provides salary and research support for individuals from underrepresented backgrounds who are committed to leading independent clinical trials, with a focus on fostering their career development through mentorship. The program is crucial for addressing health disparities in cancer outcomes and encourages applications from those facing systemic barriers in the field. Interested applicants can receive up to $100,000 annually for salaries and an additional $30,000 for research-related expenses, with applications due by November 12, 2024. For further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-21-296.html.
    Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity" (PAR-22-181), aimed at enhancing the diversity of the biomedical research workforce. This initiative invites R01 grant applications for independent research projects that align with the scientific missions of participating NIH Institutes or Centers, specifically targeting New Investigators and At-Risk Investigators from underrepresented backgrounds, including racial and ethnic minorities and individuals with disabilities. The program emphasizes the importance of addressing health disparities and promoting diverse representation in science, with funding allocations of up to $10 million for NINDS and $5 million for NIDA/NIMH, among others, for a maximum project period of five years. Interested applicants should submit their proposals by June 6, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIAID and NIDDK Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity," aimed at enhancing diversity within the biomedical and public health research sectors. This grant supports research projects from New Investigators—those who have not previously secured substantial independent NIH funding—and At-Risk Investigators, who face potential funding loss, particularly from underrepresented backgrounds in health-related sciences. The initiative emphasizes the importance of diverse perspectives in addressing health disparities and requires applicants to demonstrate a commitment to diversity, equity, inclusion, and accessibility in their proposals. Applications are open until September 7, 2025, with no budget limits specified, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-275.html.
    Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering exploratory grants (R21 Clinical Trial Optional) aimed at advancing cancer control research. This funding opportunity encourages innovative approaches to understanding cancer etiology, behavior modification, and screening techniques, focusing on the early stages of impactful research that can significantly enhance population-based cancer research. Grants will provide up to $275,000 over two years, with a maximum of $200,000 available in a single year, and applications are due by October 8, 2024. Interested applicants can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required), aimed at supporting postdoctoral fellows from underrepresented backgrounds in transitioning to independent research positions in cancer research. This grant provides "protected time" through salary and research support for three years, enabling candidates to lead an independent clinical trial or feasibility study while fostering diversity within the NCI-funded workforce. The program is crucial for addressing significant health disparities and encourages applications from historically underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds. Interested applicants must adhere to the eligibility criteria outlined in the funding opportunity announcement, with applications due by January 7, 2025. For further inquiries, candidates can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.